Article
TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Apr 2010
Tabori Uri, Shlien Adam, Baskin Berivan, Levitt Sarah, Ray Peter, Alon Noa, Hawkins Cynthia, Bouffet Eric, Pienkowska Malgorzata, Lafay-Cousin Lucie, Gozali Alexa, Zhukova Nataliya, Shane Lisa, Gonzalez Ignacio, Finlay Jonathan, Malkin David
Abstract excerpt
PURPOSE Choroid plexus carcinomas are pediatric tumors with poor survival rates and a strong, but poorly understood, association with Li-Fraumeni syndrome (LFS). Currently, with lack of biologic predictors, most children are treated with aggressive chemoradiation protocols. PATIENTS AND METHODS We established a multi-institutional tissue and clinical database, which enabled the analysis of specific alterations of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
